You are here

  • Home
  • Archive
  • Volume 33, Issue 1
  • Correspondence on “The increasing incidence of stage IV cervical cancer in the USA: what factors are related?” by Francoeur et al

Article info

Article menu
Download PDFPDF
Letter
Correspondence on “The increasing incidence of stage IV cervical cancer in the USA: what factors are related?” by Francoeur et al

Authors

  • Geetanjali D Datta Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, California, USA Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Marie-Helene Mayrand Research Center of the Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Quebec, Canada PubMed articlesGoogle scholar articles
  • Beth A Glenn Department of Health Policy and Management, UCLA Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA UCLA Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Geetanjali D Datta, Cancer Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, California, USA; geetanjali.datta{at}cshs.org

Citation

Datta GD, Mayrand M, Glenn BA
Correspondence on “The increasing incidence of stage IV cervical cancer in the USA: what factors are related?” by Francoeur et al
International Journal of Gynecologic Cancer 2023;33:136.

Publication history

  • Accepted October 13, 2022
  • First published October 28, 2022.
Online issue publication 
May 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.